Zacks Investment Research on MSN
Will GILD's strong HIV portfolio reap rewards in 2026?
Gilead Sciences, Inc. GILD has a market-leading HIV franchise, led by flagship HIV therapies — Biktarvy and Descovy. Biktarvy ...
A 650-acre undeveloped property near Emigrant Gap is being transformed into a park with camping, trails, fishing and more ...
Ameluz® and RhodoLED® New Drug Application (NDA) and Investigational New Drug Application (IND) have successfully been transferred to ...
Explore the driving forces behind Houston's robust industrial developments, port demand and infrastructure feasibility. Plus gain valuable insights into the trends and opportunities propelling the ...
We need to revert to a fiscal rule anchored on deficit reduction to provide clarity to the market and also create space to ...
India's private credit market is increasingly dominated by real estate, absorbing 42% of deal volume in H1 FY25. This surge ...
Riti Samanta, Global Co-Head Fixed Income, Systematic Fixed Income Portfolio Manager, at Russell Investments, brings nearly 25 years of experience blending quantitative rigor with portfolio management ...
PHOENIX, AZ / ACCESS Newswire / November 20, 2025 / New Generation Consumer Group, Inc. (OTCID:NGCG) today announced that it has signed a Letter of Intent (LOI) to acquire a 51% controlling interest ...
Brookfield has executed a $1.1 billion recapitalization of its U.S. logistics portfolio, Commercial Observer can first report. The refinance featured a $752 million commercial mortgage-backed ...
Halda Therapeutics acquired by Johnson & Johnson for $3.05 billion – the largest acquisition ever across any therapeutic area for a Phase 1 company Scorpion Therapeutics acquired by Eli Lilly for Up ...
Western Midstream Partners is rated a 'Buy' due to its expanding asset portfolio, strong financials, and strategic growth in the Delaware River Basin. WES benefits from the Aris Water Solutions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results